|
Evaluation of Diindolylmethane Supplementation to Modulate Tamoxifen Efficacy in Breast Cancer: The Diindolylmethane (DIM) Efficacy StudyTo date, no prospective, randomized, placebo-controlled clinical trials have been conducted to test the hypothesis that exposure to diindolylmethane (DIM), in combination with tamoxifen (TAM), can significantly modify breast cancer risk. Yet, preliminary evidence suggests this combination... |
 More > |
|
LIvES Study
LIvES Study: Lifestyle Intervention for oVarian cancer Enhanced Survival
The CRCPHP in partnership with the Arizona Cancer Center and the national Gynecological Oncology Group of the National Cancer Institute has launched the first comprehensive study to investigate the role of a healthy diet... |
 More > |
|
Women's Health Initiative (WHI)The study started in 1993 to evaluate health outcomes in aging postmenopausal women and to identify factors associated with healthy aging. Between 1993 and 1998, more than 161,000 women between 50 and 79 years of age joined the WHI. Beginning in October 2004, participants were consented for the WHI... |
 More > |
